controlled-release

Qnexa is a controlled-release formulation that combines low doses of two older drugs: the stimulant phentermine, which cuts appetite, and topiramate, which increases t he sense of feeling full.

FDA Rejects Vivus's Obesity Drug Qnexa Jennifer Corbett Dooren 2010

Vivus said Qnexa is a controlled-release formulation that combines low doses of the stimulant phentermine, which leads to the release of the stress hormone norepinephrine to cut the body's appetite, and topiramate, which works in various ways to increase satiety, or the sense of feeling full.

Regulators to Review New Drugs to Curb Appetite Thomas Gryta 2010

Vivus said Qnexa is a controlled-release formulation that combines low doses of the stimulant phentermine, which leads to the release of the stress hormone norepinephrine to cut the body's appetite, and topiramate, which works in various ways to increase satiety, or the sense of feeling full.

Regulators to Review New Drugs to Curb Appetite Thomas Gryta 2010

Qnexa is a controlled-release formulation that combines low doses of two older drugs: the stimulant phentermine, which cuts appetite, and topiramate, which increases the sense of feeling full.

FDA Finds 'Significant' Weight Loss With Qnexa 2010

Qnexa is a controlled-release formulation that combines low doses of two older drugs: the stimulant phentermine, which cuts appetite, and topiramate, which increases the sense of feeling full.

New Diet Drugs Must Pass Unique Test 2010

Vivus said Qnexa is a controlled-release formulation that combines low doses of the stimulant phentermine, which leads to the release of the stress hormone norepinephrine to cut the body's appetite, and topiramate, which works in various ways to increase satiety, or the sense of feeling full.

Regulators to Review New Drugs to Curb Appetite Thomas Gryta 2010

Another drug, Embeda, which is a controlled-release form of morphine from Alpharma Inc.,

FDA Asks if Pain Pill Is Tamper-Proof 2008

Pain Therapeutics of San Mateo, Calif., developed a drug, Remoxy, that is a controlled-release form of the painkiller oxycodone with features that are designed to resist common methods of abuse, including crushing or dissolving a tablet in order to get the entire dose of the drug at once.

FDA Asks if Pain Pill Is Tamper-Proof 2008

Meanwhile, in Pain Therapeutics, investors picked up 10,000 calls and 4,000 puts after the FDA told the company it would not approve an application for Remoxy, an abuse-resistant controlled-release form of oxycodone, in its current form.

Drug-Company Options Active 2008

A controlled-release form of oxycodone is currently sold as OxyContin by Purdue Pharma LP, a privately held company in Stamford, Conn., but the drug has been linked to a rise in prescription-drug-abuse rates because some users crush the drug or dissolve it in water and inject it to get all the effects at once, creating a heroin-like high.

FDA Asks if Pain Pill Is Tamper-Proof 2008